Biomecite Diagnostics to Develop IBD Diagnosis Tool from UMB

Biomecite Diagnostics to Develop IBD Diagnosis Tool from UMB
The University of Maryland (UM) Ventures has established an agreement with Biomecite Diagnostics, LLM, giving the company the exclusive option for the rights to developing novel methods for diagnosing inflammatory bowel diseases (IBD) from the University of Maryland in Baltimore (UMB). The licensed technology was created by Florian Fricke and James White and is expected to improve detection of ulcerative colitis (UC) and
Subscribe or to access all post and page content.